A Review on Hematologic Malignant Patients Infected with 2019 Novel Coronavirus
Author | Ensieh Lotfali | en |
Author | Reza Ghasemi | en |
Author | Masoud Mardani | en |
Author | Azam Fattahi | en |
Author | Kamran Rezaei | en |
Author | Hossein Toreyhi | en |
Author | Sara Abolghasemi | en |
Orcid | Ensieh Lotfali [0000-0001-6709-1320] | en |
Orcid | Reza Ghasemi [0000-0002-9704-9753] | en |
Orcid | Masoud Mardani [0000-0001-6082-072X] | en |
Orcid | Azam Fattahi [0000-0003-3613-4644] | en |
Orcid | Kamran Rezaei [0000-0002-0451-3175] | en |
Orcid | Hossein Toreyhi [0000-0002-4856-6674] | en |
Orcid | Sara Abolghasemi [0000-0001-7117-6079] | en |
Issued Date | 2020-06-30 | en |
Abstract | Since late 2019, when novel coronavirus pneumonia emerged in China and spread worldwide, there has been a need for data concerning the clinical characteristics of infected immunocompromised patients. It has been reported that a significant mortality rate occurs in individuals with underlying comorbidities such as hematologic malignancies. Therefore, it is vital to illustrate the clinical manifestations and outcomes of COVID-19 in these vulnerable patients and identify safe therapeutic strategies. This study reviewed the clinical course, laboratory findings, and risk factors associated with hematologic malignant patients with COVID-19 along with the management and therapeutic regimens. | en |
DOI | https://doi.org/10.5812/archcid.107788 | en |
Keyword | Coronavirus | en |
Keyword | COVID-19 | en |
Keyword | SARS-CoV-2 | en |
Keyword | Severe Acute Respiratory Syndrome Coronavirus 2 | en |
Keyword | Hematological Malignant Patients | en |
Publisher | Brieflands | en |
Title | A Review on Hematologic Malignant Patients Infected with 2019 Novel Coronavirus | en |
Type | Review Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- archcid-15-3-107788.pdf
- Size:
- 145.65 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF